Loading clinical trials...

Study to Evaluate the Clinical Impact of a Laparoscopic Radical Prostatectomy Simulator | Clinical Trials | Clareo Health

TERMINATEDNA

Study to Evaluate the Clinical Impact of a Laparoscopic Radical Prostatectomy Simulator

A Prospective Randomized Study to Evaluate the Clinical Impact of a Laparoscopic Radical Prostatectomy Online Simulator

NCT00999960•Assistance Publique - Hôpitaux de Paris

View on ClinicalTrials.gov

Summary

To evaluate the clinical impact of an online video simulator during the learning period of laparoscopic radical prostatectomy.

Detailed Description

Objectives: To compare two different approaches in learning laparoscopic radical prostatectomy , with or without using an online video simulator Design : Prospective randomized multicentric study Methods: 20 surgeons considered as naive concerning their experience in laparoscopic radical prostatectomy will be randomized into two groups :1 group will use the online video simulator, 1 group will use usual learning methods except the online video simulator. All procedures will be recorded from the beginning till the end.A video review will be preformed concerning all the videos in order to identify the total operative time and time to perform each one of the operative steps of the procedure.Clinical , biological and histological data will be collected in order to compare the two arms.

Eligibility

Age

All ages

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Surgeon beginning his clinical experience in laparoscopic radical prostatectomy and having performed less then 30 procedures before being enrolled in the study
•Surgeon who intends to begin laparoscopic radical prostatectomy clinical practice
•Surgeons who usually perform enough cases to enroll at least 10 patients during the study inclusion time

Exclusion Criteria

•Surgeon who does not have access to high speed internet (\>1024 Ko/s)
•Surgeons who do not intend to begin laparoscopic radical prostatectomy in his clinical practice

Locations (1)

HOPITAL SAINT-LOUIS Service d'urologie

Paris, France

Key Dates

Start Date

February 1, 2010

Primary Completion Date

December 1, 2017

Completion Date

December 1, 2017

Last Updated

February 25, 2026

Enrollment

ACTUAL participants

Conditions

Prostatic NeoplasmsCancer of ProstateProstate CancerProstate Neoplasms

Interventions

Laparoscopic Radical Prostatectomy (without a simulator)

PROCEDURE

Laparoscopic Radical Prostatectomy (with a simulator)

PROCEDURE

Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells

NCT05691465

Metastatic Prostate Adenocarcinoma With Neuroendocrine DifferentiationMetastatic Prostate Neuroendocrine Carcinoma+2 more

View study

RECRUITINGPHASE2

A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

NCT06842498

Metastatic Castration-Resistant Prostate Cancer

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 25, 2026Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Study to Evaluate the Clinical Impact of a Laparoscopic Radical Prostatectomy Simulator

Inclusion Criteria

Exclusion Criteria

Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells

A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations

Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

PSMA-PET: Deep Radiomic Biomarkers of Progression and Response Prediction in Prostate Cancer

Phase 2a Study of High-Dose Testosterone Followed by Radioligand Therapy in mCRPC